ENTITY
Aurobindo Pharma

Aurobindo Pharma (ARBP IN)

160
Analysis
Health Care • India
Aurobindo Pharma is an Indian multinational pharmaceutical manufacturing company that develops, manufactures, and commercializes a wide range of generic pharmaceuticals, active pharmaceutical ingredients (APIs), and specialty formulations. The company's product portfolio covers therapeutic areas including antibiotics, anti-retrovirals, cardiovascular, central nervous system, gastroenterologicals, anti-allergics, oncology, and dermatology. It commenced operations in 1988-1989 with a single unit manufacturing semi-synthetic penicillin in Puducherry. Headquartered in Hyderabad, Telangana, India, the company was founded in 1986.
more
•30 Aug 2022 06:22

SENSEX Index Rebalance Preview: Adani Green Could Replace Dr. Reddy

Two-thirds of the way through the review period, Adani Green could replace Dr. Reddy in the index at the Dec rebalance. Passive trackers will need...

Logo
665 Views
Share
•21 Jul 2022 10:20

NIFTY100 Index Rebalance Preview: Couple of Changes in August, Then 5 More in September

There are two index changes at the close on 5 August, then there should be 5 more at the close on 29 September. Passive funds will have over 4-5...

Logo
730 Views
Share
•16 May 2022 10:15

NIFTY100 Index Rebalance Preview: Five Potential Changes in September

We see five potential changes to the NIFTY100 Index at the September rebalance. Most are high probability changes and there will be over 1.5 days...

Logo
607 Views
Share
•15 May 2022 18:17

Aurobindo Pharma (ARBP IN): Regulatory Issues Continue to Haunt the Company

Aurobindo's U.S. business is under continued pressure and fresh regulatory issue regarding its oral manufacturing facility further delays the...

Logo
480 Views
Share
•30 Mar 2022 19:20

Aurobindo-Veritaz Acquisition: No Justice

Negative net-worth and continuous loss making nature, coupled with large debt size does not do justice to the valuation. The fact that Veritaz is a...

Logo
358 Views
Share
x